Proteomic as an Exploratory Approach to Develop Vaccines Against Tick-Borne Diseases Using Lyme Borreliosis as a Test Case
Tick-borne diseases affecting humans and animals are on the rise worldwide. Vaccines constitute an effective control measure, but very few are available. We selected Lyme borreliosis, a bacterial infection transmitted by the hard tick <i>Ixodes</i>, to validate a new concept to identify...
Main Authors: | Emilie Talagrand-Reboul, Benoit Westermann, Matthieu A. Raess, Gilles Schnell, Paola Cantero, Cathy Barthel, Laurence Ehret-Sabatier, Benoit Jaulhac, Nathalie Boulanger |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-08-01
|
Series: | Vaccines |
Subjects: | |
Online Access: | https://www.mdpi.com/2076-393X/8/3/463 |
Similar Items
-
Assessment of Borrelia miyamotoi in febrile patients and ticks in Alsace, an endemic area for Lyme borreliosis in France
by: Pierre H. Boyer, et al.
Published: (2020-04-01) -
No evidence of Borrelia mayonii in an endemic area for Lyme borreliosis in France
by: Pierre H. Boyer, et al.
Published: (2017-06-01) -
Epidemiological Surveillance of Lyme Borreliosis in Bavaria, Germany, 2013–2020
by: Merle Margarete Böhmer, et al.
Published: (2021-09-01) -
Improvement of Lyme Borreliosis Agent Indication Methods
by: T. N. Orlova, et al.
Published: (2011-06-01) -
Are Differences in Presentation of Early Lyme Borreliosis in Europe and North America a Consequence of a More Frequent Spirochetemia in American Patients?
by: Vera Maraspin, et al.
Published: (2021-04-01)